Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World Setting

Background: Idarucizumab has been included in guidelines for the management of bleeding or surgical procedure in dabigatran-treated patients without need for biological monitoring. The aim of the study was to assess the prognostic value of dabigatran plasma level before reversal to test the hemostat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gendron, Nicolas, Chocron, Richard, Billoir, Paul, Brunier, Julien, Camoin-Jau, Laurence, Tuffigo, Marie, Faille, Dorothée, Teissandier, Dorian, Gay, Juliette, de Raucourt, Emmanuelle, Suner, Ludovic, Bonnet, Corentin, Martin, Anne-Céline, Lasne, Dominique, Ladhari, Chayma, Lebreton, Aurélien, Bertoletti, Laurent, Ajzenberg, Nadine, Gaussem, Pascale, Morange, Pierre-Emmanuel, Le Cam Duchez, Véronique, Viallon, Alain, Roy, Pierre-Marie, Lillo-le Louët, Agnès, Smadja, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772865/
https://www.ncbi.nlm.nih.gov/pubmed/33392223
http://dx.doi.org/10.3389/fmed.2020.599626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772865/
https://www.ncbi.nlm.nih.gov/pubmed/33392223
http://dx.doi.org/10.3389/fmed.2020.599626

Ejemplares similares